Responding to customer needs with ergonomic design
Enhancements to Thermo Scientific Finnpipette F1 and F1-ClipTip pipetting systems improve comfort.
Two pipetting systems designed for accurate liquid transfer in a range of applications spanning high-throughput pharmaceutical and biotechnology laboratories to small academic and industrial laboratories are now redesigned for enhanced comfort.
For decades, Thermo Scientific Finnpipette pipetting systems have been designed for exceptional productivity and ergonomic utility across thousands of laboratories and applications worldwide. The redesigned Finnpipette F1 pipettes and Thermo Scientific F1-ClipTip pipettes now have added features designed to improve user comfort and productivity:
“Effective liquid handling is critical to ensuring experimental accuracy and as such, users need dispensing tools that can repeatedly and reliably deliver accurate volumes,” said Kelly Miller, business director of liquid handling consumables, at Thermo Fisher Scientific. “When designing upgrades for our ClipTip and Finnpipette systems, we spent time talking to our existing customers to identify their common pain points and set out to enhance their user experience. One result of the new lightweight design is that it supports the reduction of hand fatigue, and the lower pipetting forces will decrease the risk of RSI during extended use.”
These two pipetting systems are uniquely designed for different application needs. F1-ClipTip pipettes feature an interlocking tip attachment that ensures a complete seal on every channel with minimal attachment and ejection force. Once attached, the tips are locked firmly in place and are designed not to loosen or fall off, regardless of application pressure. The F1-ClipTip pipettes are designed for medium-to-high-throughput laboratories that are concerned with ergonomics, sample security, speed and improved accuracy. The Finnpipette F1 pipettes deliver the same ergonomic benefit in a lightweight design that maximizes user comfort and reduces strain. The Super Blow-out technology for effective delivery of microvolumes makes the Finnpipette F1 an ideal system for applications that use expensive reagents and valuable samples.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance